These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27310883)

  • 1. Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis.
    Chatterjee S; Agrawal D
    Cornea; 2016 Nov; 35(11):1444-1448. PubMed ID: 27310883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
    Wan Q; Tang J; Han Y; Wang D; Ye H
    Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study between ciclosporine A eye drop (2%) and tacrolimus eye ointment (0.03%) in management of children with refractory vernal keratoconjunctivitis.
    Heikal MA; Soliman TT; Abousaif WS; Shebl AA
    Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):353-361. PubMed ID: 34453603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis.
    Al-Amri AM; Mirza AG; Al-Hakami AM
    Middle East Afr J Ophthalmol; 2016; 23(1):135-8. PubMed ID: 26957853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.
    Liu FY; Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study.
    Attas-Fox L; Barkana Y; Iskhakov V; Rayvich S; Gerber Y; Morad Y; Avni I; Zadok D
    Curr Eye Res; 2008 Jul; 33(7):545-9. PubMed ID: 18600486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis.
    Kheirkhah A; Zavareh MK; Farzbod F; Mahbod M; Behrouz MJ
    Eye (Lond); 2011 Jul; 25(7):872-80. PubMed ID: 21475312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vernal keratoconjunctivitis in Thailand.
    Kosrirukvongs P; Vichyanond P; Wongsawad W
    Asian Pac J Allergy Immunol; 2003 Mar; 21(1):25-30. PubMed ID: 12931748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial.
    Müller EG; Santos MSD; Freitas D; Gomes JÁP; Belfort R
    Arq Bras Oftalmol; 2017 Jun; 80(3):154-158. PubMed ID: 28832739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
    Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis.
    Al-Amri AM
    Am J Ophthalmol; 2014 Feb; 157(2):280-6. PubMed ID: 24439439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monotherapy of topical tacrolimus 0.03% in the treatment of vernal keratoconjunctivitis in the pediatric population.
    Samyukta SK; Pawar N; Ravindran M; Allapitchai F; Rengappa R
    J AAPOS; 2019 Feb; 23(1):36.e1-36.e5. PubMed ID: 30664932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tear Tacrolimus Levels and Clinical Response After Adjunct Therapy With Cutaneous Application of Tacrolimus 0.1% Over Upper Eyelid Skin in Chronic Vernal Keratoconjunctivitis.
    Bardoloi P; Vanathi M; Velpandian T; Laxmi M; Gupta N; Lomi N; Tandon R
    Cornea; 2024 Jul; 43(7):820-827. PubMed ID: 37921523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid-Sparing Effect of 0.1% Tacrolimus Eye Drop for Treatment of Shield Ulcer and Corneal Epitheliopathy in Refractory Allergic Ocular Diseases.
    Miyazaki D; Fukushima A; Ohashi Y; Ebihara N; Uchio E; Okamoto S; Shoji J; Takamura E; Nakagawa Y; Namba K; Fujishima H
    Ophthalmology; 2017 Mar; 124(3):287-294. PubMed ID: 28017421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus.
    Malhotra C; Singh H; Jain AK; Gupta A; Ram J
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1083-1091. PubMed ID: 33764241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
    Akpek EK; Dart JK; Watson S; Christen W; Dursun D; Yoo S; O'Brien TP; Schein OD; Gottsch JD
    Ophthalmology; 2004 Mar; 111(3):476-82. PubMed ID: 15019322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
    De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P
    Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases.
    Miyazaki D; Tominaga T; Kakimaru-Hasegawa A; Nagata Y; Hasegawa J; Inoue Y
    Ophthalmology; 2008 Jun; 115(6):988-992.e5. PubMed ID: 17900694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.